Literature DB >> 17932839

Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals.

Abdulrahman Abdulla Kader1, Angamuthu Kumar, Katapadi Ananthkrishna Kamath.   

Abstract

Fecal carriage of extended-spectrum beta-lactamase (ESBL)-producing organisms was assessed in 272 inpatients, 162 outpatients, and 426 asymptomatic healthy individuals. Of 860 stool samples cultured, 152 (17.7%) yielded ESBL-producing organisms. Isolates were recovered from 71 (26.1%) of the inpatients, 25 (15.4%) of the outpatients, and 56 (13.1%) of the healthy individuals. These findings suggest that the community could be a reservoir of ESBL-producing organisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932839     DOI: 10.1086/519865

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  27 in total

Review 1.  Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.

Authors:  Frauke Mattner; Franz-C Bange; Elisabeth Meyer; Harald Seifert; Thomas A Wichelhaus; Iris F Chaberny
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

2.  Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Matteo Bassetti; Francesco Giuseppe De Rosa; Teresa Spanu; Eugenia Di Meco; Angela Raffaella Losito; Andrea Parisini; Nicole Pagani; Roberto Cauda
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

3.  Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.

Authors:  M Arnan; C Gudiol; L Calatayud; J Liñares; M Á Dominguez; M Batlle; J M Ribera; J Carratalà; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-30       Impact factor: 3.267

4.  Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.

Authors:  Thomas Tängdén; Otto Cars; Asa Melhus; Elisabeth Löwdin
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 5.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

6.  High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients.

Authors:  Aránzazu Valverde; Fabio Grill; Teresa M Coque; Vicente Pintado; Fernando Baquero; Rafael Cantón; Javier Cobo
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

7.  High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.

Authors:  Todisoa Andriatahina; Frédérique Randrianirina; Eliosa Ratsima Hariniana; Antoine Talarmin; Honoré Raobijaona; Yves Buisson; Vincent Richard
Journal:  BMC Infect Dis       Date:  2010-07-12       Impact factor: 3.090

8.  Simultaneous gut colonisation and infection by ESBL-producing Escherichia coli in hospitalised patients.

Authors:  Johny Asir; Shashikala Nair; Sheela Devi; Kenchappa Prashanth; Rajagopalan Saranathan; Reba Kanungo
Journal:  Australas Med J       Date:  2015-06-30

9.  Species-level analysis of DNA sequence data from the NIH Human Microbiome Project.

Authors:  Sean Conlan; Heidi H Kong; Julia A Segre
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.

Authors:  Matthieu Domenech de Cellès; Jean-Ralph Zahar; Véronique Abadie; Didier Guillemot
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.